You just read:

UPDATED -- JHL Biotech Announces China Approves Phase I and Phase III Clinical Trial Application for Bevacizumab Biosimilar to Treat Cancer

News provided by

JHL Biotech, Inc.

16 Oct, 2018, 20:22 BST